1. Home
  2. PRME vs MYI Comparison

PRME vs MYI Comparison

Compare PRME & MYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • MYI
  • Stock Information
  • Founded
  • PRME 2019
  • MYI 1992
  • Country
  • PRME United States
  • MYI United States
  • Employees
  • PRME N/A
  • MYI N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • MYI Investment Bankers/Brokers/Service
  • Sector
  • PRME Health Care
  • MYI Finance
  • Exchange
  • PRME Nasdaq
  • MYI Nasdaq
  • Market Cap
  • PRME 624.0M
  • MYI 701.9M
  • IPO Year
  • PRME 2022
  • MYI N/A
  • Fundamental
  • Price
  • PRME $3.72
  • MYI $10.68
  • Analyst Decision
  • PRME Buy
  • MYI
  • Analyst Count
  • PRME 6
  • MYI 0
  • Target Price
  • PRME $8.88
  • MYI N/A
  • AVG Volume (30 Days)
  • PRME 3.0M
  • MYI 256.7K
  • Earning Date
  • PRME 08-07-2025
  • MYI 01-01-0001
  • Dividend Yield
  • PRME N/A
  • MYI 4.81%
  • EPS Growth
  • PRME N/A
  • MYI N/A
  • EPS
  • PRME N/A
  • MYI N/A
  • Revenue
  • PRME $4,961,000.00
  • MYI N/A
  • Revenue This Year
  • PRME $179.58
  • MYI N/A
  • Revenue Next Year
  • PRME N/A
  • MYI N/A
  • P/E Ratio
  • PRME N/A
  • MYI N/A
  • Revenue Growth
  • PRME 739.42
  • MYI N/A
  • 52 Week Low
  • PRME $1.11
  • MYI $9.32
  • 52 Week High
  • PRME $5.17
  • MYI $11.70
  • Technical
  • Relative Strength Index (RSI)
  • PRME 54.32
  • MYI 64.79
  • Support Level
  • PRME $3.09
  • MYI $10.54
  • Resistance Level
  • PRME $3.49
  • MYI $10.60
  • Average True Range (ATR)
  • PRME 0.25
  • MYI 0.07
  • MACD
  • PRME 0.01
  • MYI 0.01
  • Stochastic Oscillator
  • PRME 95.49
  • MYI 100.00

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About MYI Blackrock MuniYield Quality Fund III Inc

BLACKROCK MUNIYIELD QUALITY FUND III, INC. is a investment management company. Its investment objective is to provide shareholders with a high level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in various sectors such as Transportation; Utilities; Health; Education; Tobacco and others.

Share on Social Networks: